Literature DB >> 33387587

Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes.

Michael S Torbenson1.   

Abstract

Hepatocellular carcinomas are not a homogenous group of tumors but have multiple layers of heterogeneity. This heterogeneity has been studied for many years with the goal to individualize care for patients and has led to the identification of numerous hepatocellular carcinoma subtypes, defined by morphology and or molecular methods. This article reviews both gross and histological levels of heterogeneity within hepatocellular carcinoma, with a focus on histological findings, reviewing how different levels of histological heterogeneity are used as building blocks to construct morphological hepatocellular carcinoma subtypes. The current best practice for defining a morphological subtype is outlined. Then, the definition for thirteen distinct hepatocellular carcinoma subtypes is reviewed. For each of these subtypes, unresolved issues regarding their definitions are highlighted, including recommendations for these problematic areas. Finally, three methods for improving the research on hepatocellular carcinoma subtypes are proposed: (1) Use a systemic, rigorous approach for defining hepatocellular carcinoma subtypes (four-point model); (2) Once definitions for a subtype are established, it should be followed in research studies, as this common denominator enhances the ability to compare results between studies; and (3) Studies of subtypes will be more effective when morphological and molecular results are used in synergistic and iterative study designs where the results of one approach are used to refine and sharpen the results of the other. These and related efforts to better understand heterogeneity within hepatocellular carcinoma are the most promising avenue for improving patient care by individualizing patient care.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Clear cell; Fibrolamellar; Growth patterns; Hepatocellular carcinoma; Heterogeneity; Steatohepatitic; Subtypes

Mesh:

Year:  2020        PMID: 33387587      PMCID: PMC9258523          DOI: 10.1016/j.humpath.2020.12.009

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.526


  56 in total

1.  Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining.

Authors:  Alan K Meeker; Wesley R Gage; Jessica L Hicks; Inpakala Simon; Jonathan R Coffman; Elizabeth A Platz; Gerrun E March; Angelo M De Marzo
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

2.  Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Jeong-Hoon Lee; Goh Eun Chung; Su Jong Yu; Sang Youn Hwang; Joon Suk Kim; Hwi Young Kim; Jung-Hwan Yoon; Hyo-Suk Lee; Nam-Joon Yi; Kyung-Suk Suh; Kuhn Uk Lee; Ja-June Jang; Yoon Jun Kim
Journal:  J Clin Gastroenterol       Date:  2011-01       Impact factor: 3.062

3.  Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.

Authors:  Marianne Ziol; Nicolas Poté; Giuliana Amaddeo; Alexis Laurent; Jean-Charles Nault; Frédéric Oberti; Charlotte Costentin; Sophie Michalak; Mohamed Bouattour; Claire Francoz; Georges Philippe Pageaux; Jeanne Ramos; Thomas Decaens; Alain Luciani; Boris Guiu; Valérie Vilgrain; Christophe Aubé; Jonathan Derman; Cécile Charpy; Jessica Zucman-Rossi; Nathalie Barget; Olivier Seror; Nathalie Ganne-Carrié; Valérie Paradis; Julien Calderaro
Journal:  Hepatology       Date:  2018-05-09       Impact factor: 17.425

4.  Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.

Authors:  Xin Yin; Bo-Heng Zhang; Shuang-Jian Qiu; Zheng-Gang Ren; Jian Zhou; Xiao-Hong Chen; Ying Zhou; Jia Fan
Journal:  Ann Surg Oncol       Date:  2012-03-27       Impact factor: 5.344

5.  Pedunculated hepatocellular carcinoma: clinicopathologic study of 18 surgically resected cases.

Authors:  Chun-Nan Yeh; Wei-Chen Lee; Long-Bin Jeng; Miin-Fu Chen
Journal:  World J Surg       Date:  2002-06-24       Impact factor: 3.352

6.  Clinicopathological study of hepatocellular carcinoma with peliotic change.

Authors:  Masaru Fujimoto; Osamu Nakashima; Mina Komuta; Toshimitsu Miyaaki; Masamichi Kojiro; Hirohisa Yano
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

7.  Steatotic and nonsteatotic scirrhous hepatocellular carcinomas reveal distinct clinicopathological features.

Authors:  Mami Hatano; Hidenori Ojima; Yohei Masugi; Hanako Tsujikawa; Nobuyoshi Hiraoka; Yae Kanai; Kazuaki Shimada; Masahiro Shinoda; Michiie Sakamoto
Journal:  Hum Pathol       Date:  2018-12-28       Impact factor: 3.466

8.  Steatohepatitic Variant of Hepatocellular Carcinoma Is Associated With Both Alcoholic Steatohepatitis and Nonalcoholic Steatohepatitis: A Study of 2 Cohorts With Molecular Insights.

Authors:  Jia Qin; Takaaki Higashi; Shigeki Nakagawa; Naoto Fujiwara; Yo-Ichi Yamashita; Toru Beppu; Hideo Baba; Masahiro Kobayashi; Hiromitsu Kumada; Ganesh Gunasekaran; Thomas D Schiano; Swan N Thung; Maria Isabel Fiel; Yujin Hoshida; Stephen C Ward
Journal:  Am J Surg Pathol       Date:  2020-10       Impact factor: 6.298

9.  Pure alpha-fetoprotein-producing neuroendocrine carcinoma of the pancreas: a case report.

Authors:  Xiang Zhu; Huijuan Yong; Li Zhang; Yonghui Huang; Jie Zheng; Cuiling Liu; Dianrong Xiu; Pan Zhang
Journal:  BMC Gastroenterol       Date:  2015-02-12       Impact factor: 3.067

10.  Molecular testing for the clinical diagnosis of fibrolamellar carcinoma.

Authors:  Rondell P Graham; Matthew M Yeh; Dora Lam-Himlin; Lewis R Roberts; Luigi Terracciano; Michael W Cruise; Patricia T Greipp; Riyam T Zreik; Dhanpat Jain; Nida Zaid; Safia N Salaria; Long Jin; Xiaoke Wang; Jeanette G Rustin; Sarah E Kerr; William R Sukov; David A Solomon; Sanjay Kakar; Emily Waterhouse; Ryan M Gill; Linda Ferrell; Venancio Af Alves; Deniz Nart; Funda Yilmaz; Stephanie Roessler; Thomas Longerich; Peter Schirmacher; Michael S Torbenson
Journal:  Mod Pathol       Date:  2017-09-01       Impact factor: 7.842

View more
  6 in total

1.  Morphological heterogeneity in beta-catenin-mutated hepatocellular carcinomas: implications for tumor molecular classification.

Authors:  Michael Torbenson; Chantal E McCabe; Daniel R O'Brien; Jun Yin; Tiffany Bainter; Nguyen H Tran; Saba Yasir; Zongming Eric Chen; Renu Dhanasekaran; Keun Soo Ahn; Lewis R Roberts; Chen Wang
Journal:  Hum Pathol       Date:  2021-09-27       Impact factor: 3.526

2.  Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma.

Authors:  Jian-Yao Wang; Xiang-Kun Wang; Guang-Zhi Zhu; Xin Zhou; Jun Yao; Xiao-Peng Ma; Bin Wang; Tao Peng
Journal:  BMC Cancer       Date:  2021-04-26       Impact factor: 4.430

Review 3.  Etiology, Pathogenesis, Diagnosis, and Practical Implications of Hepatocellular Neoplasms.

Authors:  Prodromos Hytiroglou; Paulette Bioulac-Sage; Neil D Theise; Christine Sempoux
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

4.  LncRNA ZNF674-AS1 Hinders Proliferation and Invasion of Hepatic Carcinoma Cells through the Glycolysis Pathway.

Authors:  Dongliang Li; Yan Xie; Jisan Sun; Li Zhang; Wentao Jiang
Journal:  J Oncol       Date:  2022-07-13       Impact factor: 4.501

5.  Hepatocellular Carcinoma in a Free-Ranging Three-Toed Sloth (Bradypus variegatus).

Authors:  Alex Junior Souza de Souza; Andreza Pinheiro Malheiros; Victor Lopes da Silva; Tereza Cristina da Silva; Bruno Cogliati; Lilian Rose Marques de Sá
Journal:  Animals (Basel)       Date:  2022-07-28       Impact factor: 3.231

Review 6.  Muscular Metastasis of Hepatocellular Carcinoma: Case Report and Literature Review.

Authors:  Akihiro Nakayama; Jun Arai; Yumi Otoyama; Ikuya Sugiura; Yoko Nakajima; Atsushi Kajiwara; Yuki Ichikawa; Shojiro Uozumi; Yuu Shimozuma; Manabu Uchikoshi; Masashi Sakaki; Sakiko Tazawa; Eisuke Shiozawa; Toshiko Yamochi; Masafumi Takimoto; Hitoshi Yoshida
Journal:  Intern Med       Date:  2021-07-03       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.